Drug Repurposing Identifies Natamycin and Avacopan as Urease-Targeted Therapeutic Candidates Against Helicobacter pylori. Patil S, Sarkar S, Jobby R, Yu S, et al. Helicobacter 2026;31:e70094.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Patil S, Sarkar S, Jobby R, Yu S, et al. Drug Repurposing Identifies Natamycin and Avacopan as Urease-Targeted Therapeutic Candidates Against Helicobacter pylori. Helicobacter 2026;31:e70094.
PMID: 41498156